CN104905373A - 一种具有降血糖功效的参贝保健饮料 - Google Patents
一种具有降血糖功效的参贝保健饮料 Download PDFInfo
- Publication number
- CN104905373A CN104905373A CN201510385146.7A CN201510385146A CN104905373A CN 104905373 A CN104905373 A CN 104905373A CN 201510385146 A CN201510385146 A CN 201510385146A CN 104905373 A CN104905373 A CN 104905373A
- Authority
- CN
- China
- Prior art keywords
- parts
- sea cucumber
- health drink
- scallop
- chinese herbal
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 230000036541 health Effects 0.000 title claims abstract description 51
- 235000020637 scallop Nutrition 0.000 title claims abstract description 48
- 241000237509 Patinopecten sp. Species 0.000 title claims abstract description 47
- 241000251511 Holothuroidea Species 0.000 title claims abstract description 45
- 239000008280 blood Substances 0.000 title claims abstract description 20
- 210000004369 blood Anatomy 0.000 title claims abstract description 20
- 230000003247 decreasing effect Effects 0.000 title abstract 3
- 241000411851 herbal medicine Species 0.000 claims abstract description 41
- 230000000694 effects Effects 0.000 claims abstract description 27
- 238000011049 filling Methods 0.000 claims abstract description 16
- 230000001954 sterilising effect Effects 0.000 claims abstract description 16
- 238000002156 mixing Methods 0.000 claims abstract description 15
- 241000112528 Ligusticum striatum Species 0.000 claims abstract description 8
- 244000228451 Stevia rebaudiana Species 0.000 claims abstract description 8
- 235000006092 Stevia rebaudiana Nutrition 0.000 claims abstract description 8
- 230000029087 digestion Effects 0.000 claims abstract description 6
- 235000015170 shellfish Nutrition 0.000 claims description 36
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims description 24
- 235000003140 Panax quinquefolius Nutrition 0.000 claims description 24
- 235000008434 ginseng Nutrition 0.000 claims description 24
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 16
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 15
- 239000000203 mixture Substances 0.000 claims description 12
- 238000002386 leaching Methods 0.000 claims description 10
- 239000007788 liquid Substances 0.000 claims description 10
- 238000004659 sterilization and disinfection Methods 0.000 claims description 10
- 238000002372 labelling Methods 0.000 claims description 8
- 235000016709 nutrition Nutrition 0.000 claims description 8
- 239000009636 Huang Qi Substances 0.000 claims description 7
- 244000046146 Pueraria lobata Species 0.000 claims description 7
- 235000010575 Pueraria lobata Nutrition 0.000 claims description 7
- 101000693530 Staphylococcus aureus Staphylokinase Proteins 0.000 claims description 5
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 claims description 5
- 235000013361 beverage Nutrition 0.000 claims description 5
- MKJXYGKVIBWPFZ-UHFFFAOYSA-L calcium lactate Chemical compound [Ca+2].CC(O)C([O-])=O.CC(O)C([O-])=O MKJXYGKVIBWPFZ-UHFFFAOYSA-L 0.000 claims description 5
- 239000001527 calcium lactate Substances 0.000 claims description 5
- 229960002401 calcium lactate Drugs 0.000 claims description 5
- 235000011086 calcium lactate Nutrition 0.000 claims description 5
- 230000009849 deactivation Effects 0.000 claims description 5
- 238000010438 heat treatment Methods 0.000 claims description 5
- 239000008361 herbal raw material Substances 0.000 claims description 5
- 238000000265 homogenisation Methods 0.000 claims description 5
- 239000012535 impurity Substances 0.000 claims description 5
- 238000005360 mashing Methods 0.000 claims description 5
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 claims description 5
- 230000001376 precipitating effect Effects 0.000 claims description 5
- 238000010298 pulverizing process Methods 0.000 claims description 5
- 239000013049 sediment Substances 0.000 claims description 5
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 claims description 5
- 229960002675 xylitol Drugs 0.000 claims description 5
- 235000010447 xylitol Nutrition 0.000 claims description 5
- 239000000811 xylitol Substances 0.000 claims description 5
- 244000131316 Panax pseudoginseng Species 0.000 claims 1
- 238000000034 method Methods 0.000 abstract description 5
- 230000008569 process Effects 0.000 abstract description 3
- 230000008901 benefit Effects 0.000 abstract description 2
- 241000045403 Astragalus propinquus Species 0.000 abstract 1
- 244000303040 Glycyrrhiza glabra Species 0.000 abstract 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 abstract 1
- 235000006533 astragalus Nutrition 0.000 abstract 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 abstract 1
- 235000011477 liquorice Nutrition 0.000 abstract 1
- 238000005728 strengthening Methods 0.000 abstract 1
- 241000208340 Araliaceae Species 0.000 description 23
- 238000012360 testing method Methods 0.000 description 7
- 206010012601 diabetes mellitus Diseases 0.000 description 6
- 235000013305 food Nutrition 0.000 description 6
- 230000002218 hypoglycaemic effect Effects 0.000 description 4
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 4
- 210000003734 kidney Anatomy 0.000 description 4
- 235000018102 proteins Nutrition 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- 239000002994 raw material Substances 0.000 description 4
- 210000001519 tissue Anatomy 0.000 description 4
- 230000008859 change Effects 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 241000238557 Decapoda Species 0.000 description 2
- 241000287828 Gallus gallus Species 0.000 description 2
- 102000004877 Insulin Human genes 0.000 description 2
- 108090001061 Insulin Proteins 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 2
- 230000004075 alteration Effects 0.000 description 2
- 230000002929 anti-fatigue Effects 0.000 description 2
- 239000002131 composite material Substances 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 230000007674 genetic toxicity Effects 0.000 description 2
- 231100000025 genetic toxicology Toxicity 0.000 description 2
- 235000013402 health food Nutrition 0.000 description 2
- 201000001881 impotence Diseases 0.000 description 2
- 229940125396 insulin Drugs 0.000 description 2
- 230000003993 interaction Effects 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 239000002398 materia medica Substances 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 231100000957 no side effect Toxicity 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 241000251730 Chondrichthyes Species 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- 241000721047 Danaus plexippus Species 0.000 description 1
- 244000000626 Daucus carota Species 0.000 description 1
- 206010013789 Dry throat Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 208000000616 Hemoptysis Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 208000001953 Hypotension Diseases 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 241000406668 Loxodonta cyclotis Species 0.000 description 1
- 208000001145 Metabolic Syndrome Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 241000237503 Pectinidae Species 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 208000034189 Sclerosis Diseases 0.000 description 1
- NYRAVIYBIHCEGB-UHFFFAOYSA-N [K].[Ca] Chemical compound [K].[Ca] NYRAVIYBIHCEGB-UHFFFAOYSA-N 0.000 description 1
- 201000000690 abdominal obesity-metabolic syndrome Diseases 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 231100000460 acute oral toxicity Toxicity 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 229940024606 amino acid Drugs 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 235000015278 beef Nutrition 0.000 description 1
- 230000006399 behavior Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 235000005770 birds nest Nutrition 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 229960005069 calcium Drugs 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 235000001465 calcium Nutrition 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 230000023852 carbohydrate metabolic process Effects 0.000 description 1
- 235000021256 carbohydrate metabolism Nutrition 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 230000009693 chronic damage Effects 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 238000010411 cooking Methods 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- PXEDJBXQKAGXNJ-QTNFYWBSSA-L disodium L-glutamate Chemical compound [Na+].[Na+].[O-]C(=O)[C@@H](N)CCC([O-])=O PXEDJBXQKAGXNJ-QTNFYWBSSA-L 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 239000003797 essential amino acid Substances 0.000 description 1
- 235000020776 essential amino acid Nutrition 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 210000001508 eye Anatomy 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- 150000002213 flavones Chemical class 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 235000012041 food component Nutrition 0.000 description 1
- 230000009246 food effect Effects 0.000 description 1
- 235000021471 food effect Nutrition 0.000 description 1
- 230000005714 functional activity Effects 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 230000011132 hemopoiesis Effects 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 230000003345 hyperglycaemic effect Effects 0.000 description 1
- 201000001421 hyperglycemia Diseases 0.000 description 1
- 208000021822 hypotensive Diseases 0.000 description 1
- 230000001077 hypotensive effect Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 238000005304 joining Methods 0.000 description 1
- 235000004213 low-fat Nutrition 0.000 description 1
- 239000002932 luster Substances 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 231100000682 maximum tolerated dose Toxicity 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 235000013923 monosodium glutamate Nutrition 0.000 description 1
- 231100000350 mutagenesis Toxicity 0.000 description 1
- 238000002703 mutagenesis Methods 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 235000008935 nutritious Nutrition 0.000 description 1
- 230000000050 nutritive effect Effects 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 230000003285 pharmacodynamic effect Effects 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 235000014786 phosphorus Nutrition 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 239000002151 riboflavin Substances 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 235000019192 riboflavin Nutrition 0.000 description 1
- 229940073490 sodium glutamate Drugs 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 231100000820 toxicity test Toxicity 0.000 description 1
- 238000009602 toxicology test Methods 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 235000005765 wild carrot Nutrition 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/38—Other non-alcoholic beverages
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Abstract
本发明公开了一种具有降血糖功效的参贝保健饮料,是由海参、干贝和中草药原料科学配伍,优选得干贝20~30份、海参20~30份、玄参5~10份、生山药5~10份、川芎2~5份、黄芪10~15份、柴胡3~5份、葛根3~5份、玉竹2~3份、甘草3~5份、甜叶菊3~5份配方,然后按酶解、浸提、混合、调配、灌装灭菌工艺制备。该产品优势在于通过海参、干贝和中草药之间的协同作用具有显著的降血糖、补气补益、扶正固本,抗疲劳、延年益寿等功效,安全无副作用,食用方便,具有较好的市场应用前景。
Description
技术领域
本发明涉及一种具有降血糖功效的参贝保健饮料,特别是一种以海参、干贝和植物中草药为原料制成的参贝保健饮料,属保健食品领域。
背景技术
海参是一种重要的海洋无脊椎动物,肉质细嫩、营养丰富,是典型的高蛋白、低脂肪的食物,具有极高的营养价值和药用价值, 对于高血压、冠心病、肝炎等患者以及老年人而言是食疗佳品,它既可以增强机体的免疫力和造血功能,又可抑制多种霉菌及人类癌细胞的生长和转移等。早在一千多年前,我国就有食用海参的习惯,并将海参视为一种珍贵的滋补品,列为“海八珍”之首。《本草从新》中记载海参具有“甘、咸、温、补肾益精、壮阳疗痿”的功效,清朝《本草纲目拾遗》中记载“海参性温补,足敌人参故名海参; 味甘咸、补肾经、益精髓、消痰延、摄小便、壮阳疗痿、杀疮虫”。
干贝即扇贝的干制品,其味道、色泽、形态与干贝、干贝不相上下。古人曰:“食后三日,犹觉鸡虾乏味。”可见干贝之鲜美非同一般。干贝富含蛋白质、碳水化合物、核黄素和钙、磷、铁等多种营养成分,蛋白质含量高达61.8%,为鸡肉、牛肉、鲜对虾的3倍。矿物质的含量远在鱼翅、燕窝之上。干贝含丰富的谷氨酸钠,味道极鲜。与新鲜扇贝相比,腥味大减。干贝具有滋阴补肾、和胃调中功能,能治疗头晕目眩、咽干口渴、虚痨咳血、脾胃虚弱等症,常食有助于降血压、降胆固醇、补益健身。据记载,干贝还具有抗癌、软化血管、防止动脉硬化等功效。
目前海参、干贝作为海珍品深受广大消费者青睐,食用方式主要以即食和干制品为主,存在着一定的弊端,一是食补单一,或以海参为主,或以干贝为主;二是烹制过程中大量营养成分流失,影响功效;三是食用不便。因此,海参、干贝营养保健品的开发既能充分发挥海参、干贝的食效、药效功能,又便于消费者食用,顺应市场需求,具有较好的市场前景。
糖尿病(diadetes mellitus)是一组以长期高血糖为主要特征的代谢综合征,它是由于胰岛素缺乏和、或胰岛素生物作用障碍导致糖代谢紊乱,同时伴随脂肪、蛋白质、水和电解质代谢障碍,可并发眼、肾、神经、心血管等多器官的慢性损伤。其患病率正随着人民生活水平的提高,人口老化,生活方式的改变而迅速增加,已成为继心血管病和肿瘤之后的第三大非传染性疾病,对社会和经济带来沉重的负担。由于对糖尿病的病因和发病机制尚未充分明了,目前还没有一种药物能治愈糖尿病,患者需终身服药维持血糖平衡。近二十年来,保健食品发展非常迅猛,逐渐被人们所重视。具有辅助降血糖功能的保健食品对糖尿病患者生活质量的改善十分有益,受到越来越多患者的青睐。
中草药资源是我国传统文化的瑰宝,因其功效显著、绿色、安全、无副作用,在保健食品领域中的应用愈加广泛。研究结果表明,利用中草药研制的保健品含有丰富的营养成分,不但保留了中草药中原有的多糖、黄酮、氨基酸、钾钙等微量元素、维生素等活性营养成分,而且在生产过程中产生了大量的糖、蛋白质、人体必需氨基酸等营养成分,长期合理食用能够调节人体机能,增强免疫力、滋补强身、延年益寿等功效。近年来中草药被越来越多的用于预防和治疗糖尿病,但其应用效果亟需进一步提升。
目前,中草药在保健食品领域中的应用还存在较多的弊端,难以真正发挥中草药的保健功效。本发明针对上述问题,开发一种利用海参和复合中草药的具有降血糖功效的参贝保健饮料,满足市场对海参和中草药保健食品的需求。
发明内容
为克服现有技术的不足,本发明的目的在于提供一种具有降血糖功效的参贝保健饮料,该参贝保健饮料具有降血糖、补气补益、扶正固本,抗疲劳、延年益寿等功效,满足日益增多的糖尿病患者对高效、安全、无害降血糖保健品的需求。
本发明上述目的是通过以下技术方案予以实现的:
本发明提供一种具有降血糖功效的参贝保健饮料,其特征在于参贝保健饮料原料组成及质量配比为:干贝20~30份、海参20~30份、玄参5~10份、生山药5~10份、川芎2~5份、黄芪10~15份、柴胡3~5份、葛根3~5份、玉竹2~3份、甘草3~5份、甜叶菊3~5份。
本发明的优选技术方案是:一种具有降血糖功效的参贝保健饮料,其特征在于:其特征在于参贝保健饮料原料组成及质量配比为:干贝25份、海参25份、玄参8份、生山药7份、川芎4份、黄芪12份、柴胡4份、葛根4份、玉竹2.5份、甘草4份、甜叶菊4份。
本发明提供一种具有降血糖功效的参贝保健饮料,其特征在于通过以下步骤制备:
(1)海参、干贝预处理:采用无污染、发育正常、健康的海参、干贝,用清洁、流动的水去掉泥沙及其附着物,用组织捣碎机粉碎;
(2)酶解:将海参、干贝按比例混合,加入10倍质量比的纯净水,加入质量百分比3~5%的中性蛋白酶,混合均匀,50~60℃条件下酶解2~3h;
(3)灭活:酶解后加热煮沸,维持15~20min将酶灭活,得参贝酶解液;
(4)中草药预处理:将中草药原料按比例混合,粉碎后过200目筛;
(5)中草药浸提:加入中草药质量比50倍的纯净水,加热蒸煮30~60min;
(6)过滤:过滤,得中草药浸提液;
(7)混合:将参贝酶解液和中草药浸提液混合;
(8)离心:3000r/min离心15~20min,除去沉淀物;
(9)调配:加入1%低聚异麦芽糖、0.5%柠檬酸、0.5%木糖醇、1%乳酸钙、0.2%Vc,调整pH至7.0~7.5;
(10)均质:将调配好的饮料放置在均质机中,在均质压力25MPa,温度60~70 ℃下均质,使各种营养成分均匀化,防止产品出现分层沉淀,使产品稳定性得到进一步的保障;
(11)精滤:将均质后的保健饮料先经200目双联过滤器过滤,再经硅藻过滤机精滤以除去其中的杂质及不溶物;
(12)杀菌:调配好的保健饮料进行高温瞬时灭菌,灭菌温度为120~140℃,时间为4~6s;
(13)灌装:采用真空灌装,真空度为0.04-0.05Mpa,灌装温度控制在60-75℃,再冷却至常温即得保健饮料。
本发明提供一种具有降血糖功效的参贝保健饮料,通过动物试验进行参贝保健饮料的毒理学试验及安全性评价。小鼠急性经口毒性试验结果表明,本参贝保健饮料对小鼠急性经口最大耐受剂量大于高剂量组75mg/kg·bw; 遗传毒性试验小鼠骨髓细胞微核试验和小鼠精子畸形试验两项试验结果均为阴性,表明该参贝保健饮料无致突变作用;由大鼠30d喂养试验可知,大鼠体征行为正常、体态健康、血液及血液生化指标也无异常变化,因此75mg/kg·bw的剂量(人体推荐量的150倍)属于安全剂量;遗传毒性试验和大鼠30d喂养试验结果均为阴性,因此确定本参贝保健饮料属无毒类食品,人可以安全放心食用。
本发明提供一种具有降血糖功效的参贝保健饮料,其优势在于科学配伍干贝、海参和多种中草药,通过干贝、海参和中草药之间的协同作用能有效降血糖、补气补益、扶正固本,抗疲劳、延年益寿等功效,安全无副作用,食用方便。不同的中草药性味各异,功效存在着巨大的差异,不同的中草药组合后存在复杂的相互作用关系,且中草药之间的配比比较密切,不同配比也将使君臣佐使关系发生实质性的变化,从而使复合中草药的关系发生实质性改变。本申请通过干贝、海参与玄参、生山药、川芎、黄芪、柴胡、葛根、玉竹、甘草、甜叶菊等中草药彼此间存在复杂的相互作用关系,合理配比,取得了预料不到的技术效果,使参贝保健饮料的关系发生实质性改变,饲喂本参贝保健饮料三周后的造模试验组与对照组相比血糖含量下降51.74%,说明产品具有较好的降血糖活性;且试验结果表明改变参贝保健饮料原料组成或配比会降低参贝保健饮料的降血糖能力(P<0.01),说明干贝、海参和中草药之间的协同作用起到了显著提升参贝保健饮料功能活性的作用。
具体实施方式
下面结合实施例对本发明做进一步说明。
实施例1:
一种具有降血糖功效的参贝保健饮料,通过以下步骤制备:
(1)海参、干贝预处理:采用无污染、发育正常、健康的海参、干贝,用清洁、流动的水去掉泥沙及其附着物,用组织捣碎机粉碎;
(2)酶解:将海参、干贝按干贝20份、海参30份比例混合,加入10倍质量比的纯净水,加入质量百分比3%的中性蛋白酶,混合均匀,50~60℃条件下酶解3h;
(3)灭活:酶解后加热煮沸,维持15~20min将酶灭活,得参贝酶解液;
(4)中草药预处理:将中草药原料按玄参5份、生山药10份、川芎2份、黄芪15份、柴胡3份、葛根5份、玉竹2份、甘草5份、甜叶菊3份比例混合,粉碎后过200目筛;
(5)中草药浸提:加入中草药质量比50倍的纯净水,加热蒸煮30~60min;
(6)过滤:过滤,得中草药浸提液;
(7)混合:将参贝酶解液和中草药浸提液混合;
(8)离心:3000r/min离心15~20min,除去沉淀物;
(9)调配:加入1%低聚异麦芽糖、0.5%柠檬酸、0.5%木糖醇、1%乳酸钙、0.2%Vc,调整pH至7.0~7.5;
(10)均质:将调配好的饮料放置在均质机中,在均质压力25MPa,温度60~70 ℃下均质,使各种营养成分均匀化,防止产品出现分层沉淀,使产品稳定性得到进一步的保障;
(11)精滤:将均质后的保健饮料先经200目双联过滤器过滤,再经硅藻过滤机精滤以除去其中的杂质及不溶物;
(12)杀菌:调配好的保健饮料进行高温瞬时灭菌,灭菌温度为120~140℃,时间为4~6s;
(13)灌装:采用真空灌装,真空度为0.04-0.05Mpa,灌装温度控制在60-75℃,再冷却至常温即得保健饮料。
实施例2:
一种具有降血糖功效的参贝保健饮料,通过以下步骤制备:
(1)海参、干贝预处理:采用无污染、发育正常、健康的海参、干贝,用清洁、流动的水去掉泥沙及其附着物,用组织捣碎机粉碎;
(2)酶解:将海参、干贝按干贝25份、海参25份比例混合,加入10倍质量比的纯净水,加入质量百分比4%的中性蛋白酶,混合均匀,50~60℃条件下酶解2.5h;
(3)灭活:酶解后加热煮沸,维持15~20min将酶灭活,得参贝酶解液;
(4)中草药预处理:将中草药原料按玄参8份、生山药7份、川芎4份、黄芪12份、柴胡4份、葛根4份、玉竹2.5份、甘草4份、甜叶菊4份比例混合,粉碎后过200目筛;
(5)中草药浸提:加入中草药质量比50倍的纯净水,加热蒸煮30~60min;
(6)过滤:过滤,得中草药浸提液;
(7)混合:将参贝酶解液和中草药浸提液混合;
(8)离心:3000r/min离心15~20min,除去沉淀物;
(9)调配:加入1%低聚异麦芽糖、0.5%柠檬酸、0.5%木糖醇、1%乳酸钙、0.2%Vc,调整pH至7.0~7.5;
(10)均质:将调配好的饮料放置在均质机中,在均质压力25MPa,温度60~70 ℃下均质,使各种营养成分均匀化,防止产品出现分层沉淀,使产品稳定性得到进一步的保障;
(11)精滤:将均质后的保健饮料先经200目双联过滤器过滤,再经硅藻过滤机精滤以除去其中的杂质及不溶物;
(12)杀菌:调配好的保健饮料进行高温瞬时灭菌,灭菌温度为120~140℃,时间为4~6s;
(13)灌装:采用真空灌装,真空度为0.04-0.05Mpa,灌装温度控制在60-75℃,再冷却至常温即得保健饮料。
实施例3:
一种具有降血糖功效的参贝保健饮料,通过以下步骤制备:
(1)海参、干贝预处理:采用无污染、发育正常、健康的海参、干贝,用清洁、流动的水去掉泥沙及其附着物,用组织捣碎机粉碎;
(2)酶解:将海参、干贝按干贝30份、海参20份比例混合,加入10倍质量比的纯净水,加入质量百分比5%的中性蛋白酶,混合均匀,50~60℃条件下酶解2h;
(3)灭活:酶解后加热煮沸,维持15~20min将酶灭活,得参贝酶解液;
(4)中草药预处理:将中草药原料按玄参10份、生山药5份、川芎5份、黄芪10份、柴胡5份、葛根3份、玉竹3份、甘草3份、甜叶菊5份比例混合,粉碎后过200目筛;
(5)中草药浸提:加入中草药质量比50倍的纯净水,加热蒸煮30~60min;
(6)过滤:过滤,得中草药浸提液;
(7)混合:将参贝酶解液和中草药浸提液混合;
(8)离心:3000r/min离心15~20min,除去沉淀物;
(9)调配:加入1%低聚异麦芽糖、0.5%柠檬酸、0.5%木糖醇、1%乳酸钙、0.2%Vc,调整pH至7.0~7.5;
(10)均质:将调配好的饮料放置在均质机中,在均质压力25MPa,温度60~70 ℃下均质,使各种营养成分均匀化,防止产品出现分层沉淀,使产品稳定性得到进一步的保障;
(11)精滤:将均质后的保健饮料先经200目双联过滤器过滤,再经硅藻过滤机精滤以除去其中的杂质及不溶物;
(12)杀菌:调配好的保健饮料进行高温瞬时灭菌,灭菌温度为120~140℃,时间为4~6s;
(13)灌装:采用真空灌装,真空度为0.04-0.05Mpa,灌装温度控制在60-75℃,再冷却至常温即得保健饮料。
以上实施例仅用于说明本发明的技术方案,而非对其进行限制;尽管参照前述实施例对被发明进行了详细的说明,但对于本领域的普通技术人员来说,依然可以对前述实施例所记载的技术方案进行修改,或者对其中部分技术特征进行等同替换;而对这些修改或者替换,并不使相应技术方案的本质脱离本发明所要求保护的技术方案的精神和范围。
Claims (1)
1. 一种具有降血糖功效的参贝保健饮料,其特征在于通过以下步骤制备:
(1)海参、干贝预处理:采用无污染、发育正常、健康的海参、干贝,用清洁、流动的水去掉泥沙及其附着物,用组织捣碎机粉碎;
(2)酶解:将海参、干贝按干贝20~30份、海参20~30份比例混合,加入10倍质量比的纯净水,加入质量百分比3~5%的中性蛋白酶,混合均匀,50~60℃条件下酶解2~3h;
(3)灭活:酶解后加热煮沸,维持15~20min将酶灭活,得参贝酶解液;
(4)中草药预处理:将中草药原料按玄参5~10份、生山药5~10份、川芎2~5份、黄芪10~15份、柴胡3~5份、葛根3~5份、玉竹2~3份、甘草3~5份、甜叶菊3~5份比例混合,粉碎后过200目筛;
(5)中草药浸提:加入中草药质量比50倍的纯净水,加热蒸煮30~60min;
(6)过滤:过滤,得中草药浸提液;
(7)混合:将参贝酶解液和中草药浸提液混合;
(8)离心:3000r/min离心15~20min,除去沉淀物;
(9)调配:加入1%低聚异麦芽糖、0.5%柠檬酸、0.5%木糖醇、1%乳酸钙、0.2%Vc,调整pH至7.0~7.5;
(10)均质:将调配好的饮料放置在均质机中,在均质压力25MPa,温度60~70 ℃下均质,使各种营养成分均匀化,防止产品出现分层沉淀,使产品稳定性得到进一步的保障;
(11)精滤:将均质后的保健饮料先经200目双联过滤器过滤,再经硅藻过滤机精滤以除去其中的杂质及不溶物;
(12)杀菌:调配好的保健饮料进行高温瞬时灭菌,灭菌温度为120~140℃,时间为4~6s;
(13)灌装:采用真空灌装,真空度为0.04-0.05Mpa,灌装温度控制在60-75℃,再冷却至常温即得保健饮料。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510385146.7A CN104905373A (zh) | 2015-07-05 | 2015-07-05 | 一种具有降血糖功效的参贝保健饮料 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510385146.7A CN104905373A (zh) | 2015-07-05 | 2015-07-05 | 一种具有降血糖功效的参贝保健饮料 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN104905373A true CN104905373A (zh) | 2015-09-16 |
Family
ID=54075157
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510385146.7A Pending CN104905373A (zh) | 2015-07-05 | 2015-07-05 | 一种具有降血糖功效的参贝保健饮料 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104905373A (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115486505A (zh) * | 2022-09-21 | 2022-12-20 | 营口理工学院 | 具有辅助降血糖功效的海洋藻类多糖保健饮料及制备方法 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101015339A (zh) * | 2006-02-07 | 2007-08-15 | 林军 | 参贝精 |
CN101032335A (zh) * | 2007-04-17 | 2007-09-12 | 李永胜 | 一种降血糖组合保健品 |
CN103610072A (zh) * | 2013-10-20 | 2014-03-05 | 青岛佳日隆海洋食品有限公司 | 一种降血糖海参口服液的制造方法 |
-
2015
- 2015-07-05 CN CN201510385146.7A patent/CN104905373A/zh active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101015339A (zh) * | 2006-02-07 | 2007-08-15 | 林军 | 参贝精 |
CN101032335A (zh) * | 2007-04-17 | 2007-09-12 | 李永胜 | 一种降血糖组合保健品 |
CN103610072A (zh) * | 2013-10-20 | 2014-03-05 | 青岛佳日隆海洋食品有限公司 | 一种降血糖海参口服液的制造方法 |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115486505A (zh) * | 2022-09-21 | 2022-12-20 | 营口理工学院 | 具有辅助降血糖功效的海洋藻类多糖保健饮料及制备方法 |
CN115486505B (zh) * | 2022-09-21 | 2023-05-30 | 营口理工学院 | 具有辅助降血糖功效的海洋藻类多糖保健饮料及制备方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN105077467A (zh) | 一种具有降血糖功效的鲍参保健饮料 | |
CN105661208A (zh) | 一种具有辅助降血压功效的复合果蔬饮料 | |
CN104893935A (zh) | 一种具有延缓衰老功效的鲍参复合配制酒 | |
CN104997122A (zh) | 一种滋阴壮阳玛卡复合保健饮料 | |
CN104877882A (zh) | 一种具有降血糖功效的虾青素复合配制酒 | |
CN105011309A (zh) | 一种鲍鱼海参保健饮料 | |
CN104905373A (zh) | 一种具有降血糖功效的参贝保健饮料 | |
CN104921125A (zh) | 一种具有降血糖功效的贝参复合液 | |
CN104886586A (zh) | 一种补肾壮阳鲍贝保健饮料 | |
CN105029609A (zh) | 一种具有降血糖功效的鲍贝保健饮料 | |
CN105029607A (zh) | 一种海参干贝保健饮料 | |
CN104893930A (zh) | 一种补肾壮阳鲍参复合配制酒 | |
CN104921227A (zh) | 一种具有调节血脂功效的鲍参保健饮料 | |
CN104886705A (zh) | 一种具有延缓衰老功效的参贝保健饮料 | |
CN104946491A (zh) | 一种具有降血糖功效的鲍参复合配制酒 | |
CN105011306A (zh) | 一种补肾壮阳贝参保健饮料 | |
CN104997118A (zh) | 一种具有调节血脂功效的鲍贝保健饮料 | |
CN104905371A (zh) | 一种具有降血糖功效的参贝复合配制酒 | |
CN104893927A (zh) | 一种具有降血糖功效的鲍贝复合配制酒 | |
CN104905370A (zh) | 一种具有免疫调节功效的鲍参复合液 | |
CN109112031A (zh) | 一种蜂蜜养生酒及其制备方法 | |
CN104921126A (zh) | 一种具有延缓衰老功效的鲍参复合液 | |
CN104997119A (zh) | 一种具有降血糖功效的虾青素保健饮料 | |
CN104921226A (zh) | 一种具有延缓衰老功效的鲍贝保健饮料 | |
CN105011287A (zh) | 一种具有调节血脂功效的玫瑰花海洋功能性保健饮料 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20150916 |
|
RJ01 | Rejection of invention patent application after publication |